|1.||Lin, Bei: 26 articles (06/2015 - 03/2008)|
|2.||Liu, Juanjuan: 15 articles (06/2015 - 01/2009)|
|3.||Zhang, Shulan: 13 articles (06/2015 - 01/2009)|
|4.||Iwamori, Masao: 12 articles (06/2015 - 06/2008)|
|5.||Liu, Dawo: 10 articles (06/2015 - 01/2009)|
|6.||Yan, Limei: 8 articles (06/2015 - 01/2010)|
|7.||Gao, Jian: 8 articles (04/2015 - 01/2011)|
|8.||Hu, Zhenhua: 8 articles (04/2015 - 01/2012)|
|9.||Gao, Song: 7 articles (01/2015 - 01/2010)|
|10.||Wang, Changzhi: 6 articles (06/2015 - 01/2010)|
01/01/2011 - "This study was to characterize possible involvement of Lewis Y (Le(Y)) antigen in the drug-resistance of cancer cells. "
01/01/2011 - "Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors."
02/01/2008 - "The aim of this study was to determine if pulsed high-intensity focused ultrasound (HIFU) exposures could enhance tumor uptake of (111)In-MX-B3, a murine IgG1kappa monoclonal antibody directed against the Le(y) antigen. "
03/01/1996 - "We conducted a phase I study of 38 patients with solid tumors who failed conventional therapy and whose tumors expressed the Le(Y) antigen. "
01/01/2015 - "Immunohistochemical analysis demonstrated that both the positive expression and the overexpression of CD47 and Lewis y antigen in cancer tissues and borderline tumors were significantly higher than those in benign ovarian tumors and normal ovarian tissues (P < 0.05). "
05/01/2014 - "The purpose of this study was to investigate the relationship between the expression of CD147 and Lewis y antigen in epithelial ovarian carcinoma tissues and resistance to chemotherapeutic drugs, and its underlying clinical significance, and to analyze the correlation between the expression of CD147 and Lewis y antigen. "
01/01/2013 - "The main aims of this study were to explore the molecular structural relationship between Human epididymis protein 4 (HE4) and Lewis y antigen by determining their expression patterns and clinical significance in ovarian epithelial carcinoma. "
01/01/2013 - "The groups were injected intravenously with either 150 μg of unlabeled mAbs (controls) or 2.5 or 5 MBq 211At-mAbs directed towards the Lewis Y antigen expressed on the cell membrane of several carcinomas. "
04/01/2012 - "Expression of Lewis y antigen and TGF-β1 was significantly positively associated with epithelial carcinoma. "
04/01/2012 - "Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma."
|3.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2011 - "This study aimed to investigate the molecular structural relationship between cell adhesive molecule CD44 and Lewis y antigen, and determine the effects of Lewis y antigen on CD44-mediated adhesion and spreading of ovarian cancer cell line RMG-I and the Lewis y antigen-overexpressed cell line RMG-I-H. "
06/01/2008 - "The construction of RMG-I Lewis y high expression cell line provides a cell model for further study on the relationship between Lewis y antigen and biological behaviors in the ovarian cancer."
03/01/2008 - "To study the inhibitory effect of anti-Lewis y monoclonal antibody on proliferation, adhesion and invasion of alpha1, 2-fucosyltransferase gene transfected human ovarian cancer cell line RMG-I-H with over-expression of Lewis y antigen in vitro. "
04/01/2015 - "ANXA2 and Lewis y were present in both two ovarian cancer cells and ANXA2 contained Lewis y antigen. "
05/01/2014 - "The expression of CD147 and Lewis y antigen and the pathological stage of ovarian cancer were all independent risk factors for drug resistance and prognosis in ovarian cancer."
|4.||Neoplasm Metastasis (Metastasis)
10/01/2014 - "This study demonstrates that overexpression of the Lewis y antigen on HE4 promotes ovarian cancer cell invasion and metastasis, which is likely to be used as a target for the clinical treatment of ovarian cancer. "
01/01/2010 - "Our previous studies have shown that Lewis (y) antigen plays a positive role in the process of invasion and metastasis of ovarian cancer cells. "
01/01/2015 - "The high expression of CD47 and Lewis y antigen showed significant correlations with the clinical pathological parameters of ovarian cancer [International Federation of Gynecology and Obstetrics (FIGO) standards, lymph node metastasis, and degree of differentiation] (P < 0.05). "
01/01/2015 - "Lewis Y antigen modified CD47 is an independent risk factor for poor prognosis and promotes early ovarian cancer metastasis."
10/01/2014 - "Furthermore, the high expression of Lewis y antigen significantly enhanced the HE4-mediated invasion and metastasis of ovarian cancer cells. "
|5.||Hepatocellular Carcinoma (Hepatoma)
|8.||monoclonal antibody Hu3S193
|10.||Matrix Metalloproteinase 2 (Gelatinase A)
|1.||Drug Therapy (Chemotherapy)
|2.||Heterologous Transplantation (Xenotransplantation)
|3.||Gamma Cameras (Gamma Camera)
|5.||Complementary Therapies (Alternative Medicine)